Low proliferative level is a poor prognostic factor for colon adenocarcinoma
- Authors: Raskin GA1, Petrov SV2
-
Affiliations:
- Russian Research Centre for Radiology and Surgical Technologies, Saint-Petersburg, Russia
- Kazan State Medical University, Kazan, Russia
- Issue: Vol 95, No 3 (2014)
- Pages: 378-382
- Section: Theoretical and clinical medicine
- URL: https://journals.rcsi.science/kazanmedj/article/view/1518
- DOI: https://doi.org/10.17816/KMJ1518
- ID: 1518
Cite item
Full Text
Abstract
Aim. To match up the proliferative activity of colon adenocarcinoma cells with tumor stage and survival rate. Methods. Ki-67 protein expression was evaluated by immunohistochemical methods in 217 patients with primary colon adenocarcinoma. After epitope retrieval and endogenous peroxidase inhibiting by 3% solution of hydrogen peroxide, histologic samples were stained by antibodies to Ki-67 protein (clone SP6, dilution 1:300) and polymer systemic detection with diaminobenzidine as a chromogenic substrate. Nuclear counterstain was performed using Mayer’s hematoxylin solution. Results. Assessment of colon adenocarcinoma proliferative activity showed a significant difference between the number of cases with high (>70%) and relatively low (≤30%) proliferative levels in groups with metastatic cancers and non-metastatic tumors. In patients with no relapses, colon adenocarcinoma proliferative activity assessment showed proliferation level exceeding 70% in 21 (95%) out of 22 cases, in a single case proliferation level of 60% was found according to Ki-67, no cases of proliferation level lower than 50% was found. Statistical analysis showed that proliferative activity was significantly lower in patients with metastatic colon adenocarcinoma compared to cases of adenocarcinoma without metastases (p= 0.0019). We observe one clinical case of aggressive colon adenocarcinoma with omental, peritoneal, paraumbilical metastases in 28-year old patient, in whom proliferative activity by Ki-67 was measured as 20%. Conclusion. Low proliferative level in colon adenocarcinoma is a poor prognostic factor for possible metastasing and cancer recurrence.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
G A Raskin
Russian Research Centre for Radiology and Surgical Technologies, Saint-Petersburg, Russia
Email: rasking@list.ru
S V Petrov
Kazan State Medical University, Kazan, Russia
References
- Раскин Г.А., Орлова Р.В., Петров С.В., Протасова А.Э. Иммуногистохимическое исследование аденокарциномы толстой кишки для оценки прогностических факторов // Вестн. Санкт-Петербург. ун-та. - 2012. - Серия 11. - №1. - С. 172-182.
- Belac-Lovasic I., Petković M., Ferrari A.M. Evaluation of adjuvant chemotherapy in patients with colorectal cancer in Primorsko-Goranska and Istarska County - a twenty years retrospective study // Coll. Antropol. - 2011. - Vol. 35. - P. 111-114.
- Ferlay J., Shin H.R., Bray F. et al. GLOBOCAN 2008 v2.0, cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. - Lyon, France: International Agency for Research on Cancer; 2010. - Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
- Fluge Ø., Gravdal K., Carlsen E. et al. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis // Br. J. Cancer. - 2009. - Vol. 101, N 8. - P. 1282-1289.
- Gerdes J., Schwab U., Lemke H., Stein H. Producing of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation // Int. J. Cancer. - 1983. - Vol. 31. - P. 13-20.
- Gerdes J. Ki-67 and other proliferation markers useful for immnohistological diagnostic and prognostic evaluations in human malignancies // Semin. Cancer Biol. - 1990. - Vol. 1. - P. 99-106.
- Hoos A., Nissan A., Stojadinovic A. et al. Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum. A comprehensive analysis // Clin. Cancer Res. - 2002. - Vol. 8 - P. 38-41.
- Moertel C.G., Flemming T.R., Macdonald J.C. et al. 5-FU plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report // Ann. Intern. Med. - 1995. - Vol. 122. - P. 321-326.
- Saiwaki T., Kotera I., Sasaki M. et al. In vivo dynamics and kinetics of pKi-67: transition from a mobile to an immobile form at the onset of anaphase // Exp. Cell Res. - 2005. - Vol. 308, N 1. - P. 123-134.
- Salminen E., Palmu S., Vahlberg T. et al. Increased proliferation activity measured by immunoreactive Ki-67 is associated with survival improvement in rectal/recto sigmoid cancer // World J. Gastroenterol. - 2005. - Vol. 11, N 21. - P. 3245-3249.
- Schluter C., Duchrow M., Wohlenberg C. et al. The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins // J. Cell. Biol. - 1993. - Vol. 123, N 3. - P. 513-522.
- Starborg M., Gell K., Brundell E., Hoog C. The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression // J. Cell. Sci. - 1996. - Vol. 109. - Pt. 1. - P. 143-153.
Supplementary files
